Calciphylaxis: Clinical Trials

3 trials for Calciphylaxis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Not yet recruiting 1

Follow Calciphylaxis: new trials by email Literature Review of Calciphylaxis trials Research Report on Calciphylaxis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
SEAPORT 1: Study of INZ-701 in Adults With Hemodialysis-Dependent End-Stage Kidney Disease
INZ-701 - Calciphylaxis
Phase 1CompletedInozyme Pharma112024-02-122026-08-24
Efficacy of Lanthanum Carbonate in Calciphylaxis
lanthanum carbonate, Lanthanum for calciphylaxis - Calciphylaxis
Phase 1CompletedUniversity of Wisconsin, Madison122011-02-012014-05-20

Narrower conditions

Kidney Failure, Chronic (2)  ·  Renal Insufficiency, Chronic (2)  ·  Calcinosis (1)  ·  Calcinosis Cutis (1)  ·  Calcium Metabolism Disorders (1)  ·  Vascular Calcification (1)

Broader conditions

Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Calcinosis (2)  ·  Calcium Metabolism Disorders (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Renal Insufficiency (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)

Interventions

Lanthanum (1)  ·  lanthanum carbonate (1)  ·  tocilizumab (1)

Sponsors

Boston Medical Center (1)  ·  Inozyme Pharma (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (3)

Top investigators

Micah Chan, MD MPH (1)  ·  Vipul Chitalia, MD PhD (1)